CIK: 0001056807 · Show all filings
Period: Q4 2018 (← Previous) (Next →)
Filing Date: Feb 14, 2019
Total Value ($000): $765,187 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | CHEMOCENTRYX INC | 6,687,523 | $72,961 | 9.5% | $8.94 | — | COM | 16383L106 |
| — | ARRAY BIOPHARMA INC | 4,744,062 | $67,603 | 8.8% | $10.14 | — | COM | 04269X105 |
| — | MERUS N V | 4,514,913 | $63,209 | 8.3% | $19.33 | — | COM | N5749R100 |
| KURA | KURA ONCOLOGY INC | 2,775,156 | $38,963 | 5.1% | $12.32 | +7.6% | COM | 50127T109 |
| — | BLUEPRINT MEDICINES CORP | 574,967 | $30,996 | 4.1% | $25.16 | — | COM | 09627Y109 |
| — | MIRATI THERAPEUTICS INC | 688,851 | $29,221 | 3.8% | $49.30 | — | COM | 60468T105 |
| CYTK | CYTOKINETICS INC | 4,150,639 | $26,232 | 3.4% | $10.41 | -29.6% | COM NEW | 23282W605 |
| RCUS | ARCUS BIOSCIENCES INC | 2,411,623 | $25,973 | 3.4% | $13.70 | -14.8% | COM | 03969F109 |
| — | FIVE PRIME THERAPEUTICS INC | 2,781,346 | $25,867 | 3.4% | $14.55 | — | COM | 33830X104 |
| XOMA | XOMA CORP DEL | 1,769,029 | $22,378 | 2.9% | $6.70 | +113.5% | COM NEW | 98419J206 |
| XNCR | XENCOR INC | 593,465 | $21,460 | 2.8% | $26.15 | +40.3% | COM | 98401F105 |
| ACIU | AC IMMUNE SA | 2,230,027 | $21,074 | 2.8% | $10.00 | -5.5% | SHS | H00263105 |
| INFIQ | INFINITY PHARMACEUTICALS INC | 17,426,968 | $20,564 | 2.7% | $2.67 | -32.7% | COM | 45665G303 |
| — | PIERIS PHARMACEUTICALS INC | 7,457,921 | $19,838 | 2.6% | $4.05 | — | COM | 720795103 |
| — | ARQULE INC | 6,230,418 | $17,258 | 2.3% | $1.81 | — | COM | 04269E107 |
| — | CONCERT PHARMACEUTICALS INC | 1,150,445 | $14,438 | 1.9% | $14.18 | — | COM | 206022105 |
| ANAB | ANAPTYSBIO INC | 220,265 | $14,051 | 1.8% | $23.32 | +218.9% | COM | 032724106 |
| — | MOLECULAR TEMPLATES INC | 3,364,421 | $13,592 | 1.8% | $5.48 | — | COM | 608550109 |
| — | CALITHERA BIOSCIENCES INC | 3,298,282 | $13,226 | 1.7% | $4.97 | — | COM | 13089P101 |
| — | DICERNA PHARMACEUTICALS INC | 1,215,727 | $12,996 | 1.7% | $15.02 | — | COM | 253031108 |
| — | GALMED PHARMACEUTICALS LTD | 1,878,508 | $12,830 | 1.7% | $11.58 | — | SHS | M47238106 |
| — | VERASTEM INC | 3,513,994 | $11,807 | 1.5% | $3.19 | — | COM | 92337C104 |
| — | BIOLINERX LTD | 25,995,575 | $11,368 | 1.5% | $1.01 | — | SPONSORED ADS | 09071M106 |
| XENE | XENON PHARMACEUTICALS INC | 1,788,774 | $11,287 | 1.5% | $9.34 | -4.9% | COM | 98420N105 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 1,639,458 | $11,034 | 1.4% | $9.71 | -18.3% | COM | 74366E102 |
| — | SPRING BK PHARMACEUTICALS INC | 951,701 | $9,888 | 1.3% | $13.40 | — | COM | 849431101 |
| REPL | REPLIMUNE GROUP INC | 899,617 | $8,996 | 1.2% | $17.53 | -22.9% | COM | 76029N106 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 1,987,669 | $8,845 | 1.2% | $8.22 | -33.3% | COM | 87164F105 |
| — | VBI VACCINES INC | 5,216,857 | $8,347 | 1.1% | $3.19 | — | COM NEW | 91822J103 |
| — | MEI PHARMA INC | 2,978,708 | $7,864 | 1.0% | $3.94 | — | COM NEW | 55279B202 |
| ARGX | ARGENX SE | 80,868 | $7,769 | 1.0% | $76.85 | — | SPONSORED ADR | 04016X101 |
| CRVS | CORVUS PHARMACEUTICALS INC | 1,890,507 | $6,938 | 0.9% | $10.04 | -32.1% | COM | 221015100 |
| — | EIGER BIOPHARMACEUTICALS INC | 675,000 | $6,858 | 0.9% | $10.16 | — | COM | 28249U105 |
| — | CIDARA THERAPEUTICS INC | 2,904,684 | $6,826 | 0.9% | $4.24 | — | COM | 171757107 |
| — | IMMUNE DESIGN CORP | 5,185,383 | $6,741 | 0.9% | $3.29 | — | COM | 45252L103 |
| — | FORWARD PHARMA A/S | 8,480,079 | $6,614 | 0.9% | $5.84 | — | SPONSORED ADR | 34986J105 |
| SPRO | SPERO THERAPEUTICS INC | 843,146 | $5,185 | 0.7% | $12.08 | -32.9% | COM | 84833T103 |
| — | CTI BIOPHARMA CORP | 6,929,690 | $5,084 | 0.7% | $3.77 | — | COM NEW | 12648L601 |
| KALV | KALVISTA PHARMACEUTICALS INC | 252,693 | $4,991 | 0.7% | $13.52 | +48.7% | COM | 483497103 |
| — | ALBIREO PHARMA INC | 200,500 | $4,918 | 0.6% | $32.57 | — | COM | 01345P106 |
| — | ERYTECH PHARMA | 625,000 | $4,234 | 0.6% | $22.02 | — | SPONSORED ADR | 29604W108 |
| — | PRINCIPIA BIOPHARMA INC | 146,300 | $4,007 | 0.5% | $29.22 | — | COM | 74257L108 |
| — | ONCOMED PHARMACEUTICALS INC | 4,042,989 | $3,021 | 0.4% | $8.77 | — | COM | 68234X102 |
| — | CONTRAFECT CORP | 1,898,990 | $2,905 | 0.4% | $1.14 | — | COM | 212326102 |
| — | MERRIMACK PHARMACEUTICALS INC | 721,935 | $2,787 | 0.4% | $4.91 | — | COM NEW | 590328209 |
| — | ALPINE IMMUNE SCIENCES INC | 643,059 | $2,366 | 0.3% | $11.60 | — | COM | 02083G100 |
| — | SURFACE ONCOLOGY INC | 451,850 | $1,916 | 0.3% | $13.55 | — | COM | 86877M209 |
| — | VICAL INC | 1,285,848 | $1,517 | 0.2% | $1.83 | — | COM NEW | 925602203 |
| — | GENOCEA BIOSCIENCES INC | 5,114,455 | $1,467 | 0.2% | $1.04 | — | COM | 372427104 |
| — | ESSA PHARMA INC | 580,368 | $1,219 | 0.2% | $3.75 | — | COM NEW | 29668H708 |
| — | REGULUS THERAPEUTICS INC | 1,051,940 | $979 | 0.1% | $0.93 | — | COM NEW | 75915K200 |
| — | SUNESIS PHARMACEUTICALS INC | 2,287,860 | $951 | 0.1% | $2.76 | — | COM PAR | 867328700 |
| — | REALM THERAPEUTICS PLC | 360,866 | $668 | 0.1% | $3.25 | — | SPONSORED ADS | 75606L103 |
| — | LOXO ONCOLOGY INC | 3,944 | $552 | 0.1% | $53.87 | — | COM | 548862101 |
| IONS | IONIS PHARMACEUTICALS INC | 9,399 | $508 | 0.1% | $44.30 | +15.1% | COM | 462222100 |